Detalles de la búsqueda
1.
Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.
Vaccine
; 41(33): 4808-4822, 2023 07 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37357073
2.
Immunogenicity and safety of homologous and heterologous booster vaccination of ChAdOx1 nCoV-19 (COVISHIELD™) and BBV152 (COVAXIN®): a non-inferiority phase 4, participant and observer-blinded, randomised study.
Lancet Reg Health Southeast Asia
; : 100141, 2023 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36712811
3.
Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELDTM and COVAXIN® induced immunity in COVID-19 exposed Indians.
NPJ Vaccines
; 8(1): 134, 2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37709772
4.
Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, India.
BMJ Open
; 12(5): e059869, 2022 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35613771
Resultados
1 -
4
de 4
1
Próxima >
>>